Lv7
3500 积分 2021-12-30 加入
Difficult-to-treat rheumatoid arthritis: systematic review and meta-analysis on global prevalence
1个月前
已完结
Inappropriate treatment response to DMARDs: A pathway to difficult-to-treat rheumatoid arthritis
1个月前
已完结
Difficult-to-treat rheumatoid arthritis: systematic review and meta-analysis on global prevalence
1个月前
已关闭
Difficult-to-treat rheumatoid arthritis: systematic review and meta-analysis on global prevalence
1个月前
已关闭
Lupus nephritis-related chronic kidney disease
3个月前
已完结
Lupus nephritis
3个月前
已完结
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
4个月前
已完结
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
4个月前
已完结
Rheumatoid arthritis
4个月前
已完结
皖公网安备34019202002308
